词条 | Trifluperidol |
释义 |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 470614624 | IUPAC_name = 1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]piperidin-1-yl]butan-1-one | image = Trifluperidol.svg | width = 250 | tradename = | Drugs.com = {{drugs.com|international|trifluperidol}} | pregnancy_AU = | pregnancy_US = | legal_status = | routes_of_administration = Oral | bioavailability = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = {{cascite|changed|??}} | CAS_number = 749-13-3 | ATC_prefix = N05 | ATC_suffix = AD02 | ATC_supplemental = | PubChem = 5567 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 5366 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = R8869Q7R8I | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 15023 | C=22 | H=23 | F=4 | N=1 | O=2 | molecular_weight = 409.417 g/mol | smiles = FC(F)(F)c1cccc(c1)C3(O)CCN(CCCC(=O)c2ccc(F)cc2)CC3 | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C22H23F4NO2/c23-19-8-6-16(7-9-19)20(28)5-2-12-27-13-10-21(29,11-14-27)17-3-1-4-18(15-17)22(24,25)26/h1,3-4,6-9,15,29H,2,5,10-14H2 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = GPMXUUPHFNMNDH-UHFFFAOYSA-N }} Trifluperidol is a typical antipsychotic of the butyrophenone chemical class. It has general properties similar to those of haloperidol, but is considerably more potent by weight, and causes relatively more severe side effects, especially tardive dyskinesia and other extrapyramidal effects. It is used in the treatment of psychoses including mania and schizophrenia. It was discovered at Janssen Pharmaceutica in 1959. SynthesisReferences
8 : Alcohols|Aromatic ketones|Belgian inventions|Butyrophenone antipsychotics|Janssen Pharmaceutica|Trifluoromethyl compounds|Piperidines|Typical antipsychotics |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。